CopyFind
Telmifine CH 40mg/12.5mg Tablet
药品 📍 IN

Telmifine CH 40mg/12.5mg Tablet

131,67 ₹

Analogs of Telmifine CH 40mg/12.5mg Tablet

Find cheaper analogs and generic equivalents for Telmifine CH 40mg/12.5mg Tablet.

Ingredients

活性成分: Telmisartan; Chlorthalidone


产品概览

About Telmifine CH

Telmifine CH is a medication containing the active ingredient Telmisartan, classified as Blood pressure medication. Telmisartan, sold under the brand name Micardis among others, is a medication used to treat high blood pressure and heart failure. It is a reasonable initial treatment for high blood pressure.

Key Benefits & Uses

  • Used for: 1 INDICATIONS AND USAGE Telmisartan tablets, USP are an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower.
  • Used for: Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions
  • Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Telmisartan, the active ingredient in Telmifine CH, belongs to the Blood pressure medication class. 1 INDICATIONS AND USAGE Telmisartan tablets, USP are an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Telmifine CH. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Telmifine CH for extended periods without medical advice.

Find in Pharmacies

Compare local prices and distance for Telmifine CH 40mg/12.5mg Tablet.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.